Blog Posts

European VC Landscape – February 2023

With 410 investments, February continues following the decline of European VC investments. In our exploration of this month's landscape, we illuminate the current trends, noteworthy investments, and key personalities shaping the dynamic entrepreneurial environment.

02.02.2023

In 2023, European VC investments continue to decline for now half a year with 410 investments in February.

Number and amounts of announced funding rounds over the past 6 months*

* All data from crunchbase, as of March 6th, 2023

Software startups are once again the most popular investments

  • During the month of February, 410 financing rounds were announced.
  • The total amount invested in the announced financing rounds decreased to $2.7bn from $3.4bn in January.
  • Once again, most investments were made in Software companies, amounting to 106 investments, followed by information technology (61). In February, investments in AI companies make up the third place (41).

Top 10 industries of financed startups according to the number of conducted investments

Image_feb (9)

Antler is the most active investor of February; 164 seed rounds were conducted

Investors with the highest number of investments in February

Number and total volume of financing rounds per stage

Largest round was a Series B Round of $135.0mn

In February, most investments rounds were Seed Rounds. Despite that, the largest volume of invested money was in 56 Series A Rounds ($712.1mn).

London, UK, is once again the European startup hotspot of the month

  • Not only were the most investments conducted in the UK (#117), but the highest volume was also invested there during February ($964.6mn).
  • When ranking by invested volume instead of number of investments, Copenhagen ($144.7) takes the third place for cities and Denmark ($193.7) fourth place for countries.

In the spotlight: hemab raised $135mn in February with the help of 9 investors

Company

Industry

Biotech/Pharmaceutical

Founded in

2017, Copenhagen

One-Sentence-Pitch

Hemab is a clinical-stage biotech company developing prophylactic therapeutics for serious, underserved bleeding and thrombotic disorders.

Financing round

Money raised

$135mn

Company valuation

Series B

Type of financing round

Series B

Comment/Quote

The financing will support Hemab’s scientific and corporate growth plans through 2025, including completion of two Phase 1/2 clinical studies, initiation of pivotal studies and future pipeline evolution. (BioSpace.com)

Investors

Falls Sie mehr über Risikokapitalfinanzierung erfahren möchten, sollten Sie unseren umfassenden Ratgeber zu diesem Thema lesen: Risikokapitalfinanzierung: Ein Leitfaden für Anfänger

Trustventure berät junge Unternehmen zu Herausforderung im Finanzbereich und bietet CFO-As-A-Service-Leistungen an. Die Expertise in Fragen zur Unternehmensfinanzierung, Planung und zum Controlling schafft Transparenz und Sicherheit für Sie und Ihre Investoren. Melden Sie sich gerne über unser Kontaktformular oder schreiben Sie uns direkt an office@trustventure.de.

Other articles

Uncategorized Trustventure advised in the acquisition of aifora by CentricSoftware Centric Software®, the foremost leader in Product Lifecycle Management (PLM), just announced the acquisition of aifora™. Trustventure advised aifora's Management Team on the preparation and execution of the Exit process with active support in Due Diligence, Q&A and SPA-Negotiation within the transaction. September 19, 2023
VC Landscape European VC Landscape – July 2023 With the largest round amounting to $1.8bn, July still shows a decrease in the number of founding rounds compared to June. Explore our comprehensive assessment of this month's trends to uncover the nuances. July 2, 2023
VC Landscape European VC Landscape – June 2023 June persists in following the downward trend in the number of financial rounds since its peak in March. Notably, Artificial Intelligence and healthcare now jointly occupy the third position as the most invested industries. You can explore these and other insights in this month's evaluation. June 2, 2023
VC Landscape European VC Landscape – May 2023 With a Series D round of $250mn, May brought some significant investments and influential figures. Read everything about this month's VC Landscape in our examination. May 2, 2023
VC Landscape European VC Landscape – April 2023 In contrast to March's upward trajectory, April witnessed a notable decrease in VC investment rounds, with a difference of over $1bn in the total amount invested compared to the previous month. Gain a comprehensive grasp of this month's dynamics through our in-depth analysis. April 2, 2023
VC Landscape European VC Landscape – March 2023 Following a prolonged period of decline, could the recent upswing in VC investments during March mark a turning point for the industry? Delve into our blog post to uncover a comprehensive analysis of this month's landscape. March 2, 2023
VC Landscape European VC Landscape – January 2023 Could the prevalence of seed rounds, accounting for 40% of all the conducted rounds in January, indicate a strategic shift in investment preferences? Discover more insights in our latest analysis. January 2, 2023
All articles